Introduction

39
The identification and characterization of cell types from solid tissues and organs in the human 40 body is the necessary basis for a comprehensive reference map of all human cells 1 . Such tissue 41 atlases will provide a basis for understanding fundamental biological processes and to diagnose 42 and treat disease. Single-cell RNA-sequencing (scRNA-seq) has emerged as a key tool to 43 decompose complex tissues into cell types and states, and to investigate cellular heterogeneity 2-5 . 44 Profiling cellular heterogeneity using thousands of cells and creating tissue level cellular maps 45 require efficient and scalable scRNA-seq protocols. The development of microfluidic droplet-46 based approaches, such as Drop-seq, has enabled transcriptional profiling of thousands of cells in 47 parallel 5, 6 . Drop-seq has been used to characterize the cellular composition of a wide variety of 48 tissues and organisms, including the mouse retina 5 , malaria parasites 7 , and drosophila embryos 8 . 49 However, Drop-seq requires suspensions of intact single cells for library preparation which cannot 50 be obtained for many tissues and cell types because of extra-cellular matrix that may be hard to 51 digest, fragile cell membranes, unusual cell morphology, or large cell-size. This challenge may be 52 addressed by adapting Drop-seq to single nuclei RNA-seq (DroNc-seq 9 ). DroNc-seq obtains gene 53 expression profiles from isolated nuclei which are more amenable for direct dissociation from 54 tissues while maintaining membrane integrity. Both approaches can be used to characterize cellular 55 composition of complex tissues. Comparisons of low-throughput, high-coverage single cell and 56 single nucleus approaches suggest that both methods capture the cellular composition of 57 heterogeneous samples to a similar degree 10, 11 . However, direct comparisons of Drop-seq and 58
DroNc-seq on matched samples have been limited to cell lines 9 and, more recently, samples from 59 mouse kidneys 12 . To establish a firm understanding of the differences and similarities of Drop-seq 60
and DroNc-seq, it is necessary to compare these technologies across a spectrum of different 61 biological conditions. A crucial aspect of single cell RNA-seq approaches is to capture cellular 62 heterogeneity associated with expression changes during dynamic processes, for example during 63 differentiation. We performed a systematic comparison of Drop-seq and DroNc-seq using time-64 course data from human iPSCs differentiating into cardiomyocytes (CMs). This allowed us to 65
compare Drop-seq and DroNc-seq with respect to read depth, transcriptome composition, cell 66 types detected, and cellular differentiation trajectories. These assessments are important for 67
integrative analyses and interpretation of data produced using high-throughput single-cell and 68 single-nucleus RNA-seq in general, and with Drop-seq and DroNc-seq in particular. In addition, 69
we confirmed that inclusion of reads from intronic regions increases the sensitivity of DroNc-seq 70 and improves resolution in identifying cell types. Next, we applied DroNc-seq to frozen 71 postmortem human heart tissue to sample constituent cell types and compare them to CMs grown 72 in vitro from human iPSC. This work was conceived as part of benchmarking experiments to 73 establish the applicability of recent high-throughput single-nucleus RNA-seq for the Human Cell 74
Atlas (HCA) 1 . By identifying differences and similarities between Drop-seq and DroNc-seq, this 75 study will aid efforts such as the HCA that require the integration of single-cell and single-nucleus 76
RNA-seq data from various tissues and laboratories into a common platform. 77 78
Results
80
To quantitatively assess the similarities and differences in transcription profiles from single-cell 81 and single-nucleus RNA-seq, we performed Drop-seq and DroNc-seq, respectively, on cells 82 undergoing iPSC to CM differentiation, following an established protocol 13 . To compare seq and DroNc-seq across samples with different cellular characteristics and degrees of 84 heterogeneity, we collected cells from multiple time-points throughout the differentiation process 85 (days 0, 1, 3, 7, and 15) ( Figure 1A) . For each technique, we obtained samples from two cell lines 86 per time-point, except for time-point day 15 which contains cells from a single cell line. DroNc-87 seq also contains a single cell line for day 1. To approximate how many cell barcodes were 88 accidentally associated with 2 cells in our experiment (doublet rate), we mixed iPSCs from chimp 89 into the Drop-seq run from cell line 1 on day 7. These data confirmed a low doublet rate (<5%) 90
( Figure S1 ). The distributions of number of genes for each day of differentiation are shown in 91 Figure 1B . Overall, Drop-seq shows a higher number of genes and transcripts detected compared 92
with DroNc-seq, reflecting the greater abundance of transcripts in the intact cell, compared with 93 the nucleus alone. For our analyses, we selected cells and nuclei with at least 400 and 300 detected 94 genes (at least 1 UMI), respectively, and removed chimp cells from the day 7 sample . After  95  filtering, the mean number of genes detected per cell and per nucleus are 962 and 553, and the  96  mean number of UMI per cell, nucleus are 1474 and 721 for Drop-seq and DroNc-seq, respectively.  97  Based on the above cut-offs, we detected a total of 25,475 cells and 17,229 nuclei across all cell  98  lines and time-points for Drop-seq and DroNc-seq, respectively. Both cell lines were present at  99 each time-point in the filtered datasets ( Figure 1C ). Using raw RNA-seq reads, we found that top 100 expressed genes in Drop-seq comprised of mitochondrial and ribosomal genes, while the top gene 101
in DroNc-seq was the non-coding RNA, MALAT1 ( Figure 1D ). 102 
109
In addition to the differences in the number of genes detected in Drop-seq and DroNc-seq, DroNc-110 seq captures a significantly higher fraction of intronic reads compared with Drop-seq ( Figure 2A ). 111
Up to 50% of the reads from DroNc-seq mapped to intronic regions, while for Drop-seq, only 7% 112 of reads were intronic. This discrepancy between the two techniques is expected and likely caused 113 by the sampling of unprocessed transcripts that are enriched in the nucleus. Intronic reads will be 114 detected if the transcript was not fully processed before capture by the polydT primer. In addition, 115
internal priming 14 on polyA stretches might lead to further sampling of introns. In order to 116 understand the sources of intronic reads in our dataset, we scanned the genome for polyA stretches 117 that are at least 5 bp long, and counted their frequency within and around each read with 20 bp 118 flanking regions. We found that approximately 40% of the intronic reads and their 20-bp flanking 119 regions contained at least one polyA stretches and that these polyA stretches were specifically 120 enriched towards the 3' end of reads ( Figure S3 ). This suggests internal priming as a contributing 121 mechanism for intronic read sampling. RNA-seq reads aligning to introns have been used to 122 quantify gene expression levels previously 11, 12 . Indeed, incorporating intronic reads to quantify 123 gene expression level improves the gene detection rate in DroNc-seq by ~2 times on average 124 ( Figure 2B ). This increase in detection rate leads to recovery of gene expression for cells which 125 would otherwise not be detected, as demonstrated by examples from mesoderm and cardiac genes 126 ( Figure 2C ). These data suggest that inclusion of introns can be used to compensate for the smaller 127 amount of nuclear RNA compared with whole cells. Accordingly, we incorporated intronic reads 128 into our analysis pipeline to improve gene detection rates in DroNc-seq. After intron inclusion, we 129 recovered 1.5 times more nuclei, bringing our total to 25,429 nuclei using a minimum of 300 genes 130 detected per nucleus. In addition, the mean number of UMI per cell increased from 721 to 918, 131 while the mean number of genes detected per cell increased from 553 to 672. 132 
140
To identify systematic differences in gene-specific detection rates between Drop-seq and DroNc-141 seq, we obtained differentially expressed genes (DEGs) between the two techniques for matched 142 time-points and cell lines. As a comparison, we also performed differential gene expression 143 analyses between time-points and between cell lines within each technique. We detected 144 substantially more genes with differential expression between the two techniques than we observed 145 between different time-points or cell lines ( Figure 2D ). This phenomenon was most pronounced 146 for highly significant genes and became less pronounced at more lenient thresholds of log fold-147 change ( Figure S11 ). The differentially detected genes directly reflect the sampling differences in 148 cellular components for the two techniques. GO analysis on DEGs between Drop-seq and DroNc-149 seq revealed functional annotations associated with the sampling of different cellular components 150 of the two techniques ( Figure S5 ). In particular, 5% of genes detected at higher levels in DroNc-151 seq were lncRNAs (compared to 1% in Drop-seq), while 20% and 6% of genes detected at higher 152 levels in Drop-seq were mitochondrial and ribosomal transcripts, respectively ( Figure 2E ). 153 154
Next, we tested if the differences between Drop-seq and DroNc-seq in the number of detected UMI 155 and enriched gene sets lead to inconsistent detection of cell types and variation in the inferred 156 differentiation trajectory. To infer cell types found with Drop-seq and DroNc-seq data, we 157 performed clustering of cells separately for each technique. We used the R package Seurat 15 to 158 perform normalization, dimensionality reduction, clustering, and visualization of individual cells, 159 grouped by cell types (see Methods). Cell types were assigned to clusters based on comparison of 160 genes that are significantly upregulated in the cluster to known marker genes. All genes were tested 161 for differential expression using a negative binomial likelihood ratio test within the Seurat package 162 and p-values were adjusted for multiple testing using Bonferroni correction. For each cluster, we 163 ordered genes by their average log-fold-change (logFC) in descending order to identify marker 164 genes, as genes associated with cell type have a large fold-change in expression. Note that p-values 165 (raw and adjusted) for all marker genes are small (adjusted p < 10 -5 ). We used the top marker genes 166
for each cluster to identify cell type specific genes (Figures S6 and S7) . We found that the clusters 167 identified by Drop-seq and DroNc-seq captured the anticipated differentiation from iPSCs to CMs 168 over the course of 7 days ( Figure 3A and B, Supplemental Figure 4 ). The cluster formed by cells 169 from early time-points day 0 and day 1 contained pluripotent stem cells ( Figure 3A Table S1 shows the marker genes used to identify each cell type and its corresponding cellular 189
prevalence. This comparison supported that both Drop-seq and DroNc-seq can identify the 190 predominant cell types expected in a population. Importantly, the identified clusters showed 191 expression of similar sets of genes in both techniques indicating that, despite differences in 192 detection rate between the techniques and preferential detection of specific subsets of genes the 193 identification of major cell types remained largely unaffected. 194 195 To test how concordant the cluster assignment of Drop-seq and DroNc-seq are with bulk RNA-196 seq of similar cell types, we aggregated clusters representing iPSCs and iPSCs-CMs into pseudo-197 bulk samples. We compared these pseudo-bulk data to bulk RNA-seq data obtained from a 198 previous study 17 . A total of 91 bulk RNA-seq samples composed of human iPSCs (n=18), iPSCs 199 differentiating into CMs (n=51), and adult primary heart tissue (n=22) were used for a correlation 200 analysis against pseudo-bulk iPSCs and CMs ( Figure 3E ). Drop-seq generally outperforms DroNc-201 seq for all three sample types regardless of pseudo-bulk type by ~ 50%, which is expected as bulk 202
RNA-seq and Drop-seq both capture mRNA from whole cells. The iPSC pseudo-bulk samples of 203 both methods are best correlated with iPSCs, followed by iPSC-Cardiomyocytes and primary heart 204 tissue, as expected. For CM pseudo-bulk, both methods are best correlated with iPSC-205 cardiomyocytes, followed by primary heart tissue, and iPSCs. 206 207
The time-series data allowed us to compare differentiation dynamics of iPSCs captured by seq and DroNc-seq. We observed that several cell types were present in more than one time-point 209 (Figures 3 F, G). In particular, iPSCs were observed in days 0 and 1, while CMs are observed in 210 days 7 and 15 in both Drop-seq and DroNc-seq data. Detection of the same or similar cell types 211 across time-points should therefore enable us to reconstruct continuous single-cell differentiation 212 trajectories 14, 18, 19 in an unsupervised manner to characterize the temporal relationship between 213 different cell populations. Accordingly, we reconstructed differentiation trajectories of the cells 214 from DroNc-seq and Drop-seq data using Monocle 19 . In order to reduce computational time, we 215 selected the top 700 cells based on the number of genes detected at each time-point, for a total of 216 3,500 cells and used them to reconstruct the single-cell trajectory during iPSC to CM 217 differentiation. 
241
The comparison of Drop-seq and DroNc-seq data was motivated by the fact that Drop-seq cannot 242 be applied to generate single-cell RNA-seq data from adult primary heart tissue, but DroNc-seq 243 potentially can. Having established that DroNc-seq provides data ostensibly similar to Drop-seq 244 in our in vitro setup, we applied DroNc-seq to frozen human heart tissue to identify possible 245 cardiac cell sub-types and non-cardiac cells within the tissue. 246 247
We detected a total of 4,796 nuclei based on the presence of distinct cell barcodes using DroNc-248 seq on tissue from an adult human male heart. We used both introns and exons to quantify number 249 of reads per nucleus, with mean number of genes and UMIs as 361 and 823, respectively. To focus 250 our analyses on good quality nuclei, our analyses used the top 30% (1,491) of cells based on the 251 number of genes detected. We performed cell type analysis on the heart cells using the same 252 procedure as described for the in vitro samples. As expected, the majority of cells (~82%) were 253
CMs and myofibroblasts ( Fig. 4A ). Figure 4B shows the distribution of marker genes for each cell 254 type obtained using negative binomial likelihood ratio test. A cluster was identified as CMs ( Figure  255 4A, pink cluster) based on marker genes TNNT2 (logFC=0.71), MYH6 (logFC=0.87), and 256 MYBPC3 (logFC=1.38). A second cluster was identified as likely myofibroblasts ( Figure 4A , dark-257 green cluster) expressing the collagen genes COL5A2 (logFC=1.95) and COL6A3 (logFC=1.92) 258
and periostin (POSTN). Finally, a third cluster was identified as endothelial cells ( Figure 4A , grey 259 cluster) based on vascular endothelial growth factor receptor FLT1 (logFC=2.4) and blood clotting 260
protein VWF (logFC=1.77). A fourth clusr expressing CPE (logFC=2.4) and ENPEP (logFC=2.5) 261
was identified likely representing myofibroblasts ( Figure 4A , black cluster). Additional marker 262 genes are listed in Figure S10 , which shows the top 10 upregulated genes in terms of logFC in 263 each cluster. 264 265
To better understand the cell type composition of the primary heart tissue, we first aggregated data 266 from all nuclei into a pseudo-bulk heart sample and compared these to bulk data from iPSCs, iPSC-267
CMs, and primary heart tissue as before. We found that the pseudo-bulk heart sample most closely 268 correlated with bulk RNA-seq data obtained from primary hearts, followed by iPSC-CMs. No 269 correlation was observed with bulk iPSCs ( Figure 4C ). Second, to compare the heart nuclei data 270
with the in vitro model we compared single nuclei of the heart to the DroNc-seq on iPSC-CMs 271 using correlation analysis. Figure 4D shows a bi-clustered heatmap of the confirms the clustering pattern found in Figure 4A , which demonstrates the presence of non-275 cardiomyocytes within the single-nuclei primary heart sample. In particular, the cluster identified 276
as CMs ( Figure 4A , pink cluster) has stronger correlation values with the iPSC-CMs than the 277 myofibroblasts and endothelial cells ( Figure 4A , dark-green and grey clusters). Clustering the rows 278 also revealed the relative correlation strengths of the two iPSC-CMs clusters with the primary heart 279 nuclei. In particular, the 'Cardiomyocyte 2' cluster generally has stronger correlation with the 280 primary heart nuclei than the 'Cardiomyocyte 1' cluster. This is could potentially reflect the 281 observation that 'Cardiomyocyte 2' was associated with cells collected on day of our 282 differentiation protocol and therefore to closer towards the mature state of CMs. We used iPSCs 283
as an out-group for which we expect no correlation with primary heart nuclei, which is observed 284 to be the case ( Figure 4D ). 285 As expected, the number of UMIs per nucleus in DroNc-seq are lower than those for cells in seq. Consequently, the gene detection rate in DroNc-seq was significantly lower than for Drop-313 seq ( Figure 1C ). However, given the high number of reads in DroNc-seq that mapped to intronic 314 regions we reasoned that inclusion of such reads might increase the gene detection rate. Indeed, 315
intron inclusion significantly increased the sensitivity of DroNc-seq and improved cluster 316 separation and cell type identification, in agreement with previous studies 10-12 . We also found that 317 the inclusion of introns increased gene detection rate in single nuclei samples. Of note, a significant 318
proportion of the intronic reads seems to originate not from transcripts primed at the 3' end but 319 from direct priming to polyA stretches in introns 14 (Figure 2) . While such reads still scale with the 320 expression level of a transcript, the assumption that transcript levels are uniquely quantified by a 321 single UMI may be violated in these cases. 322 323
Given the difference in input material, i.e., cellular vs. nuclear RNA, it is not surprising that we 324 found a significant proportion of genes that are differentially expressed between Drop-seq and 325
DroNc-seq samples. Some of the most highly enriched sets of genes reflected the technical 326 differences between the two technologies. Genes specifically enriched in Drop-seq are ribosomal 327 and mitochondrial. DroNc-seq presumably loses these transcripts that are predominantly localized 328
in the cytoplasm. Conversely, as a class, lncRNAs are enriched in DroNc-seq which agrees with 329 the nuclear localization of many of them. 330 331
Expression profiles in Drop-seq and DroNc-seq confirmed the differentiation of iPSCs into CMs 332 and revealed major cell types found within the in vitro differentiation model of iPSC-CMs. These 333 data also confirmed heterogeneity observed during differentiation. Drop-seq and DroNc-seq 334 detected a population of cardiac progenitors with cellular prevalence 23.3% and 18.2%, 335
respectively. They also both detected two clusters representing CMs: cardiomyocyte 1 (16.1% and 336 5.6% prevalence) and cardiomyocyte 2 (4.2% and 12.7% prevalence). Both methods also revealed 337 a population of cells, 'Alternative lineage 1', that might represent alternative fate or that failed to 338 reprogram fully, which accounted for 5.9% and 11.3% of all cells in Drop-seq and DroNc-seq, 339
respectively. The presence of non-CMs during late-stage is expected for the in vitro differentiation 340 model and has been observed previously 16 . Accordingly, the proportion of cells differentiating into 341
CMs expressing TNNT2, assessed by FACS, varies widely between 20-80% 13 . Based on our cell 342 type assignment in Drop-seq data, we obtained 28% and 29% cardiomyocytes on day 7 for the two 343 cell lines and 70% CMs on day 15 for cell line 2, which fall within the expected range. 344 345
Drop-seq revealed an additional smaller cluster (purple, 'Alternative lineage 2', expression of 346 FLT1 and comprising 1.4% of the total population) for which we did not find an equivalent cell 347 population in DroNc-seq. The reasons behind the failure of DroNc-seq to identify the small 348 fraction of cells identified as 'Alternative lineage 2' in Drop-seq may be due to the lower capture 349 rate of DroNc-seq (mean number of detected genes was 672) compared to Drop-Seq (mean number 350 of detected genes was 962) ( Figure S8 ) which might result failure of the clustering approach to 351 resolve this sub-population in DroNc-seq, or due to the preferential loss of the particular cell type 352 arising from DroNc-seq's nuclei dissociation protocol. The mean number of genes detected in this 353 subpopulation in Drop-seq was 1032, representing the cluster with the highest gene detection rate. 354 It is possible that this facilitated the detection of this cluster in Drop-seq while the lower detection 355 rate in DroNc-seq combined with the small number of cells corresponding to this cluster in the 356 sample lead to the loss of this population during clustering. However, we cannot rule out specific 357 loss or selection biases for of the cell type introduced during DroNc-seq sample preparation. 358 359 We chose the iPSC-to-CM differentiation because in addition to cell type detection, the highly 360 heterogenous but temporally coordinated process allowed us to compare cellular lineages inferred 361 based on Drop-seq and DroNc-seq data, respectively. Indeed, we were able to infer similar 362 trajectories for both Drop-seq and DroNc-seq ( Figure 3H and I) . Both trajectories show continuous 363 differentiation of iPSCs into cardiac progenitors along a single path, which then branches into CM 364 and non-cardiac cells (progenitor cells and alternative lineages). This suggests that a substantial 365
proportion of cells identified as CM progenitors in our cluster analysis are diverging from the 366 differentiation trajectory relatively early on and ultimately are not becoming mature 367 cardiomyocytes 16 . In the case of Drop-seq 'Alternative lineage 1' and 'Cardiac progenitor' cells 368 are branching off on two separate points, while for DroNc-seq both populations are on one branch. 369
The additional branching point might reflect the higher resolution achieved by Drop-seq. 370 371
Compared with bulk samples, Drop-seq pseudo-bulk is closer to tissue-level expression than 372
DroNc-seq. This is expected as the tissue data represents RNA-seq data generated using whole 373 cells, rather than nuclei. However, this difference does not mask cell type specific differences in 374 the degree of correlation with bulk samples from iPSCs, iPSC-CM, and heart. Both Drop-seq and 375
DroNc-seq CM pseudo-bulk correlate the best with bulk iPSC-CMs samples followed by primary 376 heart tissue and iPSCs. While the iPSCs correlate best with the bulk iPSCs for both methods. The 377 comparison with bulk samples provides further evidence for the cell type labels that were assigned 378 based on marker genes. 379 380
Having demonstrated that Drop-seq and DroNc-seq performed similarly in detecting heart-like cell 381 types, we applied DroNc-seq to primary heart tissue from adult human male. As expected, cell 382 type analysis of the tissue revealed mostly CMs (43%) and (myo)fibroblasts (39%), as well as a 383 smaller population of endothelial cells (12%). Interestingly, TNNT2 was detected in all the cell 384 types but was significantly upregulated in the CM cluster. TNNT2 being a marker gene for CMs 385
suggested the possibility that all nuclei are of the same broad category of cell type. Correlating 386 transcription profiles from primary heart nuclei with the iPSC-derived CM nuclei further supports 387 the inferred cell types from the primary heart tissue. The transcriptome profiles of primary heart 388 nuclei that were assigned to the 'Cardiomyocyte' cluster are more strongly correlated with the 389 profile of iPSC-CMs compared with primary heart nuclei in other clusters. 390 391
Sequencing of additional cells and increased read depth will help to increase the resolution and 392 potentially lead to detection of additional cell types. At each time-point, cells were harvested from 100 mm plates by treating with Accutase (BD 421
Biosciences, #561527) to generate a single cell suspension; from Day 7 onward, a cell scraper was 422 also employed to release adherent cells from plates. Cells were centrifuged at 300 xg for 5 minutes 423
and supernatant was aspirated off. Cells were washed 3 times with 1X PBS, 0.01% BSA (NEB, 424 #B9000S), henceforth called PBS-BSA). 10 μL of cells was combined with trypan blue for 425 counting in an NI hemocytometer (InCyto, DHC-N01-2). Viability of cells at each time point was 426 recorded (see Table 1 ). Cells were also labelled with a combination of 4′,6-diamidino-2-427 phenylindole or DAPI (Sigma, Cat #D9542) and Wheat Germ Agglutinin (WGA; Thermo Fisher 428 Scientific, W11262) to assess nucleus and cell membrane integrity under fluorescence imaging, as 429
shown in Figure 5A . 400,000 cells were taken and suspended in 2 mL PBS-BSA (200,000 cells/mL) 430
for Drop-seq, and the remaining cells were used for nuclei isolation for DroNc-seq. 431 432 were used to determine if the cellular membrane had properly lysed for each cell. If intact cells 440 were still present, 2 mL of sample was moved to a glass dounce tissue grinder (Sigma, Cat #D8938) 441 and dounced 5 times. After douncing, another 10 μL sample was imaged under the microscope 442
with DAPI and WGA staining as before to determine if high-quality, intact nuclei were obtained 443 (see Figure 5B ). We adjusted the number of dounces until only nuclei were found. As iPSCs 444 differentiated further into CMs, the number of required dounces needed to be increased. For 445 example, day 3 of differentiation required 5 dounces to obtain proper cell lysis and intact nuclei, 446 while Day 7 required 12 dounces. Nuclei were spun down at 500 xg for 5 minutes at 4 • C. After 447 centrifugation, the nuclei were washed with nuclei suspension buffer (NSB; 1X PBS, 0.01% BSA, 448 and 0.1% RNAse inhibitor (Lucigen, #F83923)), resuspended in 2 mL NSB and filtered using a 449 35 μm cell strainer (Corning, #352235). 10 μL of nuclei suspension was sampled using a NI 450
hemocytometer and the concentration adjusted to a final loading concentration of 300,000 451 nuclei/mL in NSB of which 2 mL was used for DroNc-seq. 452 453
Microfluidic Co-encapsulation of Cells/Nuclei and Barcoded Beads 454
For Drop-seq, 2 mL of cells at 200,000 cells/mL in PBS-BSA was loaded in a 3 mL syringe (BD, 455 #309657). A custom-built 90 μm Drop-seq microfluidic device (CAD file supplied separately) was 456 used for droplet generation, creating droplets smaller than the standard Drop-seq protocol. 5 We 457 chose to use the 90 µm droplets because the effective concentration of cellular RNA in the 90 um 458 drops is doubled, leading to better RNA capture, compared to 125 µm droplets used in Drop-seq. 459
Indeed, we see an increase in RNA capture for cells of smaller size, such as iPSC. We note that 460 the increase in capture efficiency often fails to translate to larger sized cells (~15 μm), likely due 461
to the higher concentrations of the lysed cell's endogenous RNase and lysosomes, etc. in the drop. 462
Cells at 200,000 cells/mL and ~2,600,000 droplets/mL (droplet volume is ~380 pL) amounts to a 463
Poisson loading distribution with λ ≈ 0.076. DNA barcoded beads (ChemGenes, Macosko-2011-464 10(V+)) were washed, filtered, and suspended in Drop-seq lysis buffer, also at 200,000 beads/mL 465 and kept in suspension under constant stirring using a magnetic tumble stirrer and flea magnet 466 (V&P Scientific, VP 710 Series, VP 782N-3-150). Beads and cells were co-flowed into the device, 467 each at 3 mL/hr, along with a surfactant-oil mix (BioRad, #1864006) at 12 mL/hr that was loaded 468 into a 10 mL syringe (BD, #302995) and used as the outer carrier oil phase. Reverse emulsions 469 droplets were generated at ~3000 drops/sec and collected in two batches of 20 minutes each in 50 470 mL tubes (Genesee Scientific, #28-106). After collection, the standard Drop-seq protocol for bead 471 recovery, washing, and reverse transcription was followed. 5 After washes and DNaseI treatment 472 as per Drop-seq protocol 5 , cDNA amplification was performed on 75,000 RNA-DNA barcode 473 bead conjugates in a 96-well plate (Genesee Scientific, #24-302) loaded at 5000 beads per well, 474
for a total of 15 wells and amplified for 15 PCR cycles using template switching. 5 Post-PCR 475 cleanup was performed by removing the STAMPs (Single Transcriptome Attached to Micro-476
Particles 5 ) and pooling the supernatant from the wells together into a single 1.7 mL tube (Genesee 477
Scientific, #22-281LR) along with 0.6X Ampure XP beads (Beckman Coulter, #A63880). After 478 adding the Ampure beads to the PCR product, the tube was incubated at room temperature for 2 479 minutes on a thermomixer (Eppendorf Thermomixer C, #5382000023) set to 1250 rpm, and for 480 another 2 minutes on bench for stationary incubation. Next, the tube was placed on a magnet, and 481 4X 80% ethanol washes were performed with 1 mL ethanol added in each wash. cDNA was eluted 482 in 150 μL of water and the concentration and library size were measured using Qubit 3 fluorometer 483 (Thermo Fisher) and BioAnalyzer High Sensitivity Chip (Agilent, #5067-4626). A BioAnalyzer 484 trace is provided in Figure 5C as an example of the amplified transcriptome obtained from a Drop-485 seq run. 450 pg of the cDNA library was used in Nextera Library prep, instead of 650 pg as 486
suggested in the Drop-seq protocol 5 to obtain Nextera libraries between 300 -600 bp. 487 488
For DroNc-seq, a 75 μm microfluidic device 9 was used. 2 mL of nuclei at 300,000 nuclei/mL were 489 loaded into a 3 mL syringe and flowed at 1.5 mL/hr. Barcoded beads were filtered with a 40 μm 490 filter to select for smaller beads to prevent clogging events in the relatively smaller microfluidic 491 channels. 2 mL of beads were suspended at 350,000 beads/mL in Drop-seq lysis buffer, loaded in 492 a 3 mL syringe, kept suspended through a magnetic tumble stirrer, and flowed at 1.5 mL/hr, along 493 with carrier oil-surfactant mix loaded in 10 mL syringe and flowed at 12 mL/hr. Droplets were 494 generated at ~4,500 drops/sec and collected in 50 mL tubes in two batches for 22 minutes each. 495
After collection, the standard DroNc-seq protocol for bead recovery and reverse transcription was 496 followed. 9 cDNA amplification was performed on the STAMPs as above, for 15-20 wells at 5000 497 beads per well, for 15 PCR cycles. Cleanup was performed after removing the STAMPs and adding 498 0.6X Ampure XP beads (Beckman Coulter, #A63880) to the pooled supernatant followed by room 499 temperature incubation for 2-minutes on an Eppendorf thermomixer set to 1250 rpm and another 500 2-minute stationary incubation. Tubes were placed on a magnet and beads were allowed to migrate 501 prior to 4X washes in 80% ethanol. cDNA was eluted in 10 μL of water per well and DNA 502 concentration was measured using a Qubit 3 fluorometer (Thermo Fisher). 650 pg of DNA was 503 used in each Nextera reaction for fragmenting, tagging, and amplifying to create Nextera library. 504
Nextera library size and concentrations were determined using a BioAnalyzer DNA High 505
Sensitivity Chip (Agilent, #5067-4626). 506 507 508 Figure 
513
Nuclei Isolation from Adult Human Heart Tissue 514
Post-mortem human heart tissue was provided by the National Disease Research Interchange 515 (NDRI). The sample (m, 68 yrs) had been stored at -80 o C for 11 years before it was processed for 516
DroNc-seq. The frozen tissue sample was weighed and cut with a scalpel and 32.8 mg of sample 517 was processed, by mincing with the scalpel. The sample was placed into a glass dounce tissue 518 grinder (Sigma, Cat #D8938) with 2 mL of ice-cold EZ-Prep lysis buffer from the Nuclei EZ-prep 519
Isolation Kit (Sigma, Cat #NUC-101). The tissue was dounced 25 times with Pestle A, transferred 520 to a conical tube with an additional 2 mL lysis buffer, and incubated on ice for 5 minutes. Sample 521 was then centrifuged at 500 xg for 5 minutes at 4 • C. Supernatant was aspirated off and replaced 522 with 2 mL lysis buffer. Sample was transferred back to the tissue grinder and dounced 25 times 523
with Pestle B. Sample was then put back into a conical tube with an additional 2 mL lysis buffer, 524 centrifuged, and washed with 4 mL lysis buffer followed by 5-minute incubation on ice. 10 μL of 525 sample was taken and combined with DAPI and Wheat Germ Agglutinin (WGA) and put into an 526 NI hemocytometer (InCyto, DHC-N01-2) to check for nuclei quality. If whole cells were still 527 present, additional douncing with Pestle B was performed (additional 25-35 dounces expected) 528 before checking again using DAPI and WGA. The resulting nuclei were centrifuged, lysis buffer 529 was aspirated, and nuclei were washed and resuspended in Nuclei Suspension Buffer (NSB; 1x 530 PBS, 0.01% BSA, and 0.1% RNAse inhibitor (Lucigen, #F83923)). Nuclei were filtered once with 531 a 35 μm cell strainer (Corning, #352235), once with a 20 μm filter (pluriSelect, #43-50020-01), 532
and twice with a 10 μm filter (pluriSelect, #43-50010-01) and stored on ice for processing. Nuclei 533
were counted using an NI hemocytometer and brought to a final concentration of 300,000 534 nuclei/mL in 2 mL NSB for DroNc-seq. To assess the quality of RNA from the archived heart 535 tissue, we ran an independent experiment to extract total RNA using a Qiagen kit (Qiagen, #74004) 536
and measured using a BioAnalyzer RNA 6000 Pico kit (Agilent, #5067-1513) . A RIN score of ~5 537
was obtained for this sample. 538 539
DroNc-seq on Nuclei Harvested from Heart Tissue 540
DroNc-seq was performed as previously described with a few exceptions: single 30-minute droplet 541 collection was performed using a 75 μm microfluidic device and flow rates mentioned previously. 542
During whole transcriptome amplification, 12 cycles of PCR were performed on 30 wells with 543 5000 barcoded beads per well. Clean-up was performed as described above. cDNA from each well 544 was eluted in 2 μL of water and pooled for quantification by BioAnalyzer ( Figure 5C) The differentiating iPSCs were sampled at specific timepoints during a 15-day period (days 0, 1, 558 3, 7, 15) using both Drop-seq and DroNc-seq ( Fig 1A) . A total of 17 sequencing runs were 559 performed over the course of the differentiation. Each sequencing run produced paired-end reads, 560
with one pair representing the 12 bp cell barcode and 8 bp unique molecular identifier (UMI), and 561 the second pair representing a 60 bp mRNA fragment. We developed a Snakemake 21 protocol that 562 takes a FASTQ file with such paired-end reads as input and produces an expression matrix 563
corresponding to the UMI of each gene in each cell. The protocol initially performs FastQC 22 to 564 obtain a report of read quality. Next, it creates a whitelist of cell barcodes using umi_tools 23 0.5.3, 565
which is a list of cell barcodes with at least 30k reads. Next, each paired-end read is combined into 566 a single read where the read name contains the cell barcode and UMI extracted from paired end 567 read 1, and the sequence content corresponds to paired end read 2. This is done for every paired 568 end read and placed into a single "tagged" FASTQ file. The tagged FASTQ file contains only the 569 cell barcodes found in the whitelist. Finally, the protocol trims the ends of reads to remove polyA 570 sequences and adaptors using cutadapt 24 1.15. The tagged and trimmed FASTQ file is aligned to 571 the human reference genome (version GRCh38) using the STAR 25 aligner version 2.5.3, which 572 returns a BAM file sorted by coordinate. Next, we use featureCounts 26 version 1.6.0 to assign each 573 aligned read to a feature on the genome. Finally, we use the count function from umi_tools to 574 create a count matrix representing the frequency of each feature in the BAM file. The pipeline is 575 available at github.com/aselewa/dropseq_pipeline. A total of 17 count matrices 576
were produced by this pipeline, 9 of which correspond to Drop-seq and 8 correspond to DroNc-577 seq. In order to incorporate introns into the counting process, the UMI count of a gene was 578 calculated as the sum of its exon and intron UMIs. This is particularly important for DroNc-seq as 579 approximately half the reads obtained come from intronic regions of pre-spliced mRNA. 580 GENCODE version 28 annotations contain exon features and gene features but do not contain 581 intron features. To derive an intron annotation file, we used exon and gene features. Exon regions 582
were subtracted from gene regions (on the same strand) and the remainder was counted as the 583 intron region for said gene. Then the expression level of a gene is given by the sum of the number 584 of intron and exons. 585 586
From each sequencing run, approximately 5000 cells were obtained with an average read depth of 587 30k -40k per cell. Low quality cells were filtered based on the number of genes detected. A gene 588 was considered detected in a cell if there was at least 1 UMI present. Cells with less than 400 genes 589
and nuclei with less than 300 genes detected were removed. Low quality genes were also filtered 590 if they were not detected in at least 10 cells, in order to reduce noise and computation cost. The 591 total numbers of cells remaining were approximately 23,554 and 24,318 for Drop-seq and DroNc-592 seq, respectively. After filtering, all expression matrices from Drop-seq experiments were merged 593 into a single expression matrix. The merging was done by taking the union of all genes. If a 594 particular dataset did not contain a gene that is expressed in another dataset, we set the expression 595 level to zero in the first dataset. Similarly, all expression matrices corresponding to DroNc-seq 596
were merged into a single expression matrix. Both merged matrices were processed and analyzed 597 separately downstream. Seurat 15 was used to perform normalization, clustering, and cell type 598 analysis. R scripts used for the analyses in this paper are documented at 599 github.com/aselewa/czi. 600 601
Internal Priming 602
We used the MEME 27 suite to find all 5 bp stretches of adenines using the human genome build 603
hg38. Next, we merged all 5 bp motifs in order to obtain all continuous polyA tracts. A total of ~2 604 × 10 $ motifs at least 5 bp long were identified genome-wide. BAM files from each time-point 605
were merged and only intronic reads were kept. Intronic reads were extended by 20 bp on each 606 side and intersected with the adenine motifs in a strand-specific way. The motifs were centered by 607 the coordinates of the reads they intersect with and a histogram motif of 3' positions was obtained 608 ( Figure S3 ). 609 610
Normalization and Scaling 611
Following the analysis procedure recommended by Seurat, we first normalize the count data. Each 612 cell's gene-specific UMIs were divided by the total number of UMI in the cell scaled to 10 4 , which 613
yields TP10k (transcripts per 10k) values. Figure S2 shows the relationship between the mean 614 expression (mean TP10k) and the length of the gene. The relationship is relatively weak, therefore 615 normalizing by just the library size is sufficient. A pseudo-count of 1 was added to all scaled values 616 followed by a natural log transformation. After the log-transformation, the values were 617 standardized, i.e. mean-centered and scaled such that each gene has unit variance. These log-618 normalized, and standardized data were used in downstream analyses to perform dimensionality 619 reduction and reconstruction of differentiation trajectories. 620 621
Dimensionality Reduction 622 lower read counts and were thus removed by filtering based on read depth. We only kept cells with 717 a specificity score above 0.6 yielding ~739 cells. In agreement with our assignment, > 99% of 718 these cells were associated with clusters that we identified as CMs while none were associated 719 with iPSC clusters. 720 721 Figure 
